Cargando…
Impact of Colistin Dosing on the Incidence of Nephrotoxicity in a Tertiary Care Hospital in Saudi Arabia
Colistin therapy is associated with the development of nephrotoxicity. We examined the incidence and risk factors of nephrotoxicity associated with colistin dosing. We included adult hospitalized patients who received intravenous (IV) colistin for >72 h between January 2014 and December 2015. The...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459899/ https://www.ncbi.nlm.nih.gov/pubmed/32781593 http://dx.doi.org/10.3390/antibiotics9080485 |
_version_ | 1783576476750184448 |
---|---|
author | Almutairy, Reem Aljrarri, Waad Noor, Afnan Elsamadisi, Pansy Shamas, Nour Qureshi, Mohammad Ismail, Sherine |
author_facet | Almutairy, Reem Aljrarri, Waad Noor, Afnan Elsamadisi, Pansy Shamas, Nour Qureshi, Mohammad Ismail, Sherine |
author_sort | Almutairy, Reem |
collection | PubMed |
description | Colistin therapy is associated with the development of nephrotoxicity. We examined the incidence and risk factors of nephrotoxicity associated with colistin dosing. We included adult hospitalized patients who received intravenous (IV) colistin for >72 h between January 2014 and December 2015. The primary endpoint was the incidence of colistin-associated acute kidney injury (AKI). The secondary analyses were predictors of nephrotoxicity, proportions of patients inappropriately dosed with colistin according to the Food and Drug Administration (FDA), European Medicines Agency (EMA), and Garonzik formula and clinical cure rate. We enrolled 198 patients with a mean age of 55.67 ± 19.35 years, 62% were men, and 60% were infected with multidrug-resistant organisms. AKI occurred in 44.4% (95% CI: 37.4–51.7). Multivariable analysis demonstrated that daily colistin dose per body weight (kg) was associated with AKI (OR: 1.57, 95% CI: 1.08–2.30; p = 0.02). Other significant predictors included serum albumin level, body mass index (BMI), and severity of illness. None of the patients received loading doses, however FDA-recommended dosing was achieved in 70.2% and the clinical cure rate was 13%. The incidence of colistin-associated AKI is high. Daily colistin dose, BMI, serum albumin level, and severity of illness are independent predictors of nephrotoxicity. |
format | Online Article Text |
id | pubmed-7459899 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74598992020-09-02 Impact of Colistin Dosing on the Incidence of Nephrotoxicity in a Tertiary Care Hospital in Saudi Arabia Almutairy, Reem Aljrarri, Waad Noor, Afnan Elsamadisi, Pansy Shamas, Nour Qureshi, Mohammad Ismail, Sherine Antibiotics (Basel) Article Colistin therapy is associated with the development of nephrotoxicity. We examined the incidence and risk factors of nephrotoxicity associated with colistin dosing. We included adult hospitalized patients who received intravenous (IV) colistin for >72 h between January 2014 and December 2015. The primary endpoint was the incidence of colistin-associated acute kidney injury (AKI). The secondary analyses were predictors of nephrotoxicity, proportions of patients inappropriately dosed with colistin according to the Food and Drug Administration (FDA), European Medicines Agency (EMA), and Garonzik formula and clinical cure rate. We enrolled 198 patients with a mean age of 55.67 ± 19.35 years, 62% were men, and 60% were infected with multidrug-resistant organisms. AKI occurred in 44.4% (95% CI: 37.4–51.7). Multivariable analysis demonstrated that daily colistin dose per body weight (kg) was associated with AKI (OR: 1.57, 95% CI: 1.08–2.30; p = 0.02). Other significant predictors included serum albumin level, body mass index (BMI), and severity of illness. None of the patients received loading doses, however FDA-recommended dosing was achieved in 70.2% and the clinical cure rate was 13%. The incidence of colistin-associated AKI is high. Daily colistin dose, BMI, serum albumin level, and severity of illness are independent predictors of nephrotoxicity. MDPI 2020-08-06 /pmc/articles/PMC7459899/ /pubmed/32781593 http://dx.doi.org/10.3390/antibiotics9080485 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Almutairy, Reem Aljrarri, Waad Noor, Afnan Elsamadisi, Pansy Shamas, Nour Qureshi, Mohammad Ismail, Sherine Impact of Colistin Dosing on the Incidence of Nephrotoxicity in a Tertiary Care Hospital in Saudi Arabia |
title | Impact of Colistin Dosing on the Incidence of Nephrotoxicity in a Tertiary Care Hospital in Saudi Arabia |
title_full | Impact of Colistin Dosing on the Incidence of Nephrotoxicity in a Tertiary Care Hospital in Saudi Arabia |
title_fullStr | Impact of Colistin Dosing on the Incidence of Nephrotoxicity in a Tertiary Care Hospital in Saudi Arabia |
title_full_unstemmed | Impact of Colistin Dosing on the Incidence of Nephrotoxicity in a Tertiary Care Hospital in Saudi Arabia |
title_short | Impact of Colistin Dosing on the Incidence of Nephrotoxicity in a Tertiary Care Hospital in Saudi Arabia |
title_sort | impact of colistin dosing on the incidence of nephrotoxicity in a tertiary care hospital in saudi arabia |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459899/ https://www.ncbi.nlm.nih.gov/pubmed/32781593 http://dx.doi.org/10.3390/antibiotics9080485 |
work_keys_str_mv | AT almutairyreem impactofcolistindosingontheincidenceofnephrotoxicityinatertiarycarehospitalinsaudiarabia AT aljrarriwaad impactofcolistindosingontheincidenceofnephrotoxicityinatertiarycarehospitalinsaudiarabia AT noorafnan impactofcolistindosingontheincidenceofnephrotoxicityinatertiarycarehospitalinsaudiarabia AT elsamadisipansy impactofcolistindosingontheincidenceofnephrotoxicityinatertiarycarehospitalinsaudiarabia AT shamasnour impactofcolistindosingontheincidenceofnephrotoxicityinatertiarycarehospitalinsaudiarabia AT qureshimohammad impactofcolistindosingontheincidenceofnephrotoxicityinatertiarycarehospitalinsaudiarabia AT ismailsherine impactofcolistindosingontheincidenceofnephrotoxicityinatertiarycarehospitalinsaudiarabia |